[go: up one dir, main page]

AU2002306374A1 - Genes with ES cell-specific expression - Google Patents

Genes with ES cell-specific expression

Info

Publication number
AU2002306374A1
AU2002306374A1 AU2002306374A AU2002306374A AU2002306374A1 AU 2002306374 A1 AU2002306374 A1 AU 2002306374A1 AU 2002306374 A AU2002306374 A AU 2002306374A AU 2002306374 A AU2002306374 A AU 2002306374A AU 2002306374 A1 AU2002306374 A1 AU 2002306374A1
Authority
AU
Australia
Prior art keywords
genes
cell
specific expression
expression
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002306374A
Other versions
AU2002306374B2 (en
Inventor
Eiko Kaiho
Shinya Yamanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority claimed from PCT/JP2002/005350 external-priority patent/WO2002097090A1/en
Publication of AU2002306374A1 publication Critical patent/AU2002306374A1/en
Assigned to YAMANAKA, SHINYA, DAINIPPON SUMITOMO PHARMA CO., LTD. reassignment YAMANAKA, SHINYA Request for Assignment Assignors: SUMITOMO PHARMACEUTICALS CO., LTD., YAMANAKA, SHINYA
Application granted granted Critical
Publication of AU2002306374B2 publication Critical patent/AU2002306374B2/en
Priority to AU2008201280A priority Critical patent/AU2008201280B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002306374A 2001-05-31 2002-05-31 Genes with ES cell-specific expression Ceased AU2002306374B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008201280A AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-165927 2001-05-31
JP2001165927 2001-05-31
PCT/JP2002/005350 WO2002097090A1 (en) 2001-05-31 2002-05-31 Genes with es cell-specific expression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008201280A Division AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Publications (2)

Publication Number Publication Date
AU2002306374A1 true AU2002306374A1 (en) 2003-05-08
AU2002306374B2 AU2002306374B2 (en) 2008-01-24

Family

ID=19008539

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002306374A Ceased AU2002306374B2 (en) 2001-05-31 2002-05-31 Genes with ES cell-specific expression
AU2008201280A Ceased AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008201280A Ceased AU2008201280B2 (en) 2001-05-31 2008-03-19 Genes with ES cell-specific expression

Country Status (6)

Country Link
US (3) US7250255B2 (en)
EP (2) EP1403366B1 (en)
JP (2) JP4183614B2 (en)
AU (2) AU2002306374B2 (en)
ES (2) ES2544854T3 (en)
WO (1) WO2002097090A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
JP2006521792A (en) * 2003-02-13 2006-09-28 国立大学法人京都大学 Cell undifferentiated state markers and compositions and methods for stem cell isolation and preparation
US20090203141A1 (en) * 2003-05-15 2009-08-13 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
US7964401B2 (en) * 2004-02-19 2011-06-21 Kyoto University Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3
EP1811023A4 (en) * 2004-09-29 2009-04-29 Dainippon Sumitomo Pharma Co Gene expressed specifically in es cells and utilization of the same
US20100183617A1 (en) 2005-02-23 2010-07-22 University Of Virginia Patent Foundation Compositions and methods for regulating sas1r
EP1851242A2 (en) * 2005-02-23 2007-11-07 University Of Virginia Patent Foundation Novel egg receptors for sperm proteins
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
KR101420740B1 (en) * 2005-12-13 2014-07-17 교또 다이가꾸 Nuclear initialization factor
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
CN105861443A (en) 2007-04-07 2016-08-17 怀特黑德生物医学研究所 Reprogramming of somatic cells
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
JP2008307007A (en) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
US20090239217A1 (en) * 2007-10-08 2009-09-24 University Of Florida Research Foundation, Inc. Stem-like cells in bone sarcomas
US20110033931A1 (en) * 2007-11-29 2011-02-10 Children's Hospital Of Orange County De-differentiation of human cells
US9683232B2 (en) * 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
KR101532442B1 (en) 2007-12-10 2015-06-29 고쿠리츠 다이가쿠 호진 교토 다이가쿠 Efficient method for nuclear reprogramming
CA2621155A1 (en) * 2008-02-29 2009-08-29 James Ellis Stem cell expression cassettes
ES2722198T3 (en) 2008-05-02 2019-08-08 Univ Kyoto Nuclear reprogramming method
US9394538B2 (en) 2008-05-07 2016-07-19 Shi-Lung Lin Development of universal cancer drugs and vaccines
CN105671065A (en) 2008-06-13 2016-06-15 怀特黑德生物医学研究所 Cell Programming and Reprogramming
KR102173873B1 (en) 2009-11-12 2020-11-04 브이셀 세라퓨틱스 인코포레이티드 Subpopulations of spore-like cells and uses
CN109689089A (en) 2016-05-25 2019-04-26 国家医疗保健研究所 methods and compositions for treating cancer
US11679148B2 (en) 2017-11-24 2023-06-20 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for treating cancers
EP3833383A1 (en) 2018-08-06 2021-06-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating cancers
EP4314246A1 (en) 2021-04-01 2024-02-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1475440A3 (en) * 1993-01-12 2004-11-17 The Johns Hopkins University School Of Medicine Growth differentiation factor-3
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US6207380B1 (en) 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
US6573094B1 (en) * 1997-10-16 2003-06-03 Baylor College Of Medicine F-box genes and proteins
WO2000005248A1 (en) 1998-07-24 2000-02-03 Eli Lilly And Company Human gdf-3 nucleic acids, polypeptides, vectors, host cells, methods and uses thereof
AU6181000A (en) 1999-07-29 2001-02-19 Chugai Research Institute For Molecular Medicine, Inc. Novel genes encoding protein kinase/protein phosphatase
US6908748B2 (en) 1999-07-29 2005-06-21 Kenji Sobue Genes associated with the maintenance of differentiation of smooth muscle cells
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
AU6180900A (en) 1999-07-29 2001-02-19 Chugai Seiyaku Kabushiki Kaisha Novel genes encoding protein kinase/protein phosphatase
EP1220895A1 (en) 1999-10-15 2002-07-10 Finnish Immunotechnology Ltd. Novel gene encoding a dna methyltransferase, dnmt3l
JP2001165927A (en) 1999-12-08 2001-06-22 Ngk Insulators Ltd Method and apparatus for monitoring endocrine disturbing chemical substance
CA2399681A1 (en) 2000-02-03 2001-08-09 Hyseq, Inc. Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
FR2808803B1 (en) * 2000-05-11 2004-12-10 Agronomique Inst Nat Rech MODIFIED ES CELLS AND SPECIFIC GENE OF ES CELLS

Similar Documents

Publication Publication Date Title
AU2002306374A1 (en) Genes with ES cell-specific expression
EP1403366A4 (en) Genes with es cell-specific expression
AU2002313559A1 (en) Genes
AU2002259196A1 (en) Gene expression profiling
AU2003218483A1 (en) Novel expressed genes
AU2003277149A1 (en) Synthetic genes
AU2003232122A1 (en) Ctp-extended erythropoietin
AU2001278918A1 (en) Novel lipase genes
AUPQ262599A0 (en) Gene expression
AU2003228139A1 (en) Bioreactor
AU2001242625A1 (en) Gene sequence
AU2001240103A1 (en) Reproduction-specific genes
AU2001264247A1 (en) GASC1 gene
AU2001244358A1 (en) Schizophrenia related genes
AU2003234955A1 (en) Micromanipulator
AU2003243360A1 (en) Polyamine-mediated transfection
GB0122232D0 (en) Gene expression
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU2003222965A1 (en) Schizophrenia associated genes
AUPR551201A0 (en) Neuronal cell-specific promoter
AU2001278042A1 (en) Daz genes
AUPR232800A0 (en) Gene expression